Spineart and eCential Robotics today announced the receipt of FDA 510(k) clearance for the use of an application for robotic ...

FOR IMMEDIATE RELEASE Spineart and eCential Robotics announce FDA clearance of PERLA® App for use with Op.nTM robotic ...

The FDA has cleared Spineart’s Perla TL application for use with eCential Robotics Op.nTM robotic navigation platform. The clearance will combine Spineart and eCential Robotics’ robotic-assisted spine ...

Interim data on Spineart’s Baguera-C cervical disc shows the device meets the threshold for a non-inferiority claim compared to a study control, the medtech company said March 11. Spineart plans to ...

Interim analysis of 1-level BAGUERA®C IDE study meets threshold for non-inferiorityGeneva, March 11, 2025 – Spineart, a fast-growing company in ...

Dallas, Texas and Franklin, Tennessee, March 13, 2025 — Spineart, a fast-growing company in spine surgery innovation, and eCential Robotics, an expert company in surgical robotics, proudly ...

Geneva, March 11, 2025 – Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 1-level BAGUERA®C IDE study ...

Geneva, March 11, 2025 – Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 1-level BAGUERA®C IDE study, which ...